NL-OMON44067已完成3 期
Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized study. - Dexamethasone for pain flare after radiotherapy
niversitair Medisch Centrum Utrecht0 个研究点目标入组 294 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 294
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with uncomplicated painful bone metastases, treated with 1-6 fractions of palliative radiotherapy
- •Pain intensity on a numeric rating scale of 2-8
- •Able to complete Dutch questionnaire
排除标准
- •Patients with hematological malignancies
- •Multiple sites to be irradiated
- •Previous radiotherapy for painful bone metastases
- •Current use of steroids or expected use within 2 weeks after radiotherapy
- •Life expectancy <8 weeks
研究者
相似试验
进行中（未招募）
不适用
Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized study - Dexamethasone for pain flare after radiotherapyEUCTR2010-020174-42-NLZonMw
已完成
不适用
Dexamethason for the treatment of exacerbations in multiple sclerosisISRCTN40435212niversity Medical Center Groningen (UMCG) (The Netherlands)60
撤回
4 期
Dexamethason for the treatment of exacerbations in multiple sclerosis10012303multiple sclerosisNL-OMON30002niversitair Medisch Centrum Groningen60
进行中（未招募）
不适用
Dexamethason for the treatment of exacerbations in multiple sclerosisMultiple SclerosisEUCTR2006-003113-40-NLDepartment of Neurology UMCG60
进行中（未招募）
1 期
DEX-2-TKA - analgesic efficacy and safety of one or two doses of steroid (dexamethsone) after total knee arthroplastyEUCTR2018-001099-39-DKaestved Hospital486